Due to COVID-19, many of us have postponed elective procedures this year—and that includes mammograms. In this episode, LA-based oncologist Natasha Banerjee discusses the alarming drop in breast cancer screenings since March—and the ramifications. Plus, an update on state-of-the-art treatments like immunotherapy which utilizes antibodies to boost immunity; who should be getting ultrasounds and or MRIs to screen for breast cancer; how you can tell if you have dense breasts and should be getting ultrasounds; and a rare cancer that has been linked to one type of breast implants.